Cargando…
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer
Endometrial cancer (EC) is the most common gynecologic malignancy, and it arises in the inner part of the uterus. Identification of serum biomarkers is essential for diagnosing the disease at an early stage. In this study, we selected 44 healthy controls and 44 type I EC at tumor stage 1, and we use...
Autores principales: | Ura, Blendi, Capaci, Valeria, Aloisio, Michelangelo, Di Lorenzo, Giovanni, Romano, Federico, Ricci, Giuseppe, Monasta, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405144/ https://www.ncbi.nlm.nih.gov/pubmed/36009404 http://dx.doi.org/10.3390/biomedicines10081857 |
Ejemplares similares
-
A Label-Free Proteomic Approach for the Identification of Biomarkers in the Exosome of Endometrial Cancer Serum
por: Sommella, Eduardo, et al.
Publicado: (2022) -
Phospho-DIGE Identified Phosphoproteins Involved in Pathways Related to Tumour Growth in Endometrial Cancer
por: Capaci, Valeria, et al.
Publicado: (2023) -
Gel-Based Proteomic Identification of Suprabasin as a Potential New Candidate Biomarker in Endometrial Cancer
por: Celsi, Fulvio, et al.
Publicado: (2022) -
A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers
por: Capaci, Valeria, et al.
Publicado: (2023) -
Two Dimensional-Difference in Gel Electrophoresis (2D-DIGE) Proteomic Approach for the Identification of Biomarkers in Endometrial Cancer Serum
por: Ura, Blendi, et al.
Publicado: (2021)